TransCode Therapeutics
RNAZ
RNAZ
hedge funds and large institutions have $88.6K invested in TransCode Therapeutics in 2023 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 | -$22.9K | |
| 2 | -$17K | |
| 3 | -$14K | |
| 4 |
VF
Virtu Financial
New York
|
-$11K |
| 5 |
Renaissance Technologies
New York
|
-$9K |